Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

IRS Says It Won't Extend This Year's Tax-Filing Deadline
IRS Says It Won't Extend This Year's Tax-Filing Deadline

When the coronavirus pandemic hit in full force in March, it upended normal life in a very meaningful way. Businesses were forced to shut down. Schools closed for in-person learning all over the

News on Lemonade, Bill.com, and Payoneer's SPAC Deal
News on Lemonade, Bill.com, and Payoneer's SPAC Deal

Several months ago, we did an episode of Industry Focus: Financials about two stocks we planned to add to our portfolios -- Bill.com (NYSE: BILL) and Lemonade (NYSE: LMND). Well, Bill.com just

PayPal Is Adding Customers Hand Over Fist
PayPal Is Adding Customers Hand Over Fist

To say 2020 was a year like no other might sound like a cliche, but in this case, it isn't hyperbole. The ongoing shift to digital payments accelerated on a large scale and PayPal Holdings (NASDAQ:

3 Cheap Stocks to Buy in February
3 Cheap Stocks to Buy in February

Finding cheap tech stocks these days isn't exactly easy. With the broader stock market making huge gains last year -- much of it fueled by technology companies -- some stocks that would have been

3 Dividend Stocks I'd Buy Right Now
3 Dividend Stocks I'd Buy Right Now

Dividend stocks have historically produced market-beating returns. However, it's important to point out that the biggest factor driving outperformance isn't a stock's dividend yield, but whether the

Here's Why the Best Is Yet to Come for Pinterest
Here's Why the Best Is Yet to Come for Pinterest

Pinterest (NYSE: PINS) smashed earnings estimates last week. The image-based social network reported 76% year-over-year revenue growth to $705.6 million in the fourth quarter, well ahead of the

Why Dynatrace Is a Top Cloud Analytics Stock for 2021Photo, wide shot, wide-angle lens,  Telecom equipment supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/ad10ed87-71d0-4096-a50b-ba9470f8264b.png
Why Dynatrace Is a Top Cloud Analytics Stock for 2021

Shares of cloud observability specialist Dynatrace (NYSE: DT) have been off to the races since the company made its second public debut in 2019 (it was previously acquired and later spun off from

3 Ways to Go Broke in the Stock Market -- and How to Invest Successfully Instead
3 Ways to Go Broke in the Stock Market -- and How to Invest Successfully Instead

It's possible to make a fortune investing in the stock market, even if you don't have much money to invest. Without a strategy, however, it's just as easy to lose everything.

You don't need to know

What IAC's Vimeo Spinoff Means for Investors
What IAC's Vimeo Spinoff Means for Investors

Renowned investor Barry Diller has created the anti-conglomerate in Interactive Corp (NASDAQ: IAC) by sticking to his playbook of acquiring a business, growing that business, and spinning it out

Is Corning Incorporated Stock a Buy?
Is Corning Incorporated Stock a Buy?

Material science company Corning's (NYSE: GLW) sales came roaring back in the fourth quarter and the company looks set for a very strong year. The company has a lot of good things going for it at

Two Top Gaming Stocks to Watch
Two Top Gaming Stocks to Watch

Today we take a look at two gaming giants: Activision Blizzard (NASDAQ: ATVI) and Electronic Arts (NASDAQ: EA). Both companies recently released their earnings and are still showing strength in the

You're Probably Paying Too Much for Your Car Loan. Here's What You Can Do About It.
You're Probably Paying Too Much for Your Car Loan. Here's What You Can Do About It.

Kevin Bennett is the CEO of MotoRefi, a company founded to help consumers save money on their car loans.

During an appearance on Motley Fool Live recorded on Feb. 4, Kevin joined Brendan Mathews

Is Apple Stock a Buy?
Is Apple Stock a Buy?

Two years after becoming the first publicly traded $1 trillion company, Apple (NASDAQ: AAPL) became the world's first $2 trillion company in August 2020. Such expansive growth in recent years makes

What's Wrong With Limelight Networks Today?
What's Wrong With Limelight Networks Today?

Content-delivery networks (CDN) veteran Limelight Networks (NASDAQ: LLNW) crashed on Friday due to a disappointing earnings report on the evening of Thursday, February 11. The company missed Wall

3 Moves You Can Make This Year for a Bigger Social Security Check
3 Moves You Can Make This Year for a Bigger Social Security Check

You'll probably come to rely on Social Security to some degree in retirement, whether it's for basic expenses, emergency bills, or leisure purposes. As such, it pays to do what you can to score the

More Stimulus Checks Are Coming: 3 Top Stocks to Buy if You've Got Extra Money
More Stimulus Checks Are Coming: 3 Top Stocks to Buy if You've Got Extra Money

Democrats and Republicans in the U.S. Congress are still hammering out the details of the next stimulus package, and there could be more twists and turns before the legislation is done. However, it

Is BioNano Genomics Stock a Buy?
Is BioNano Genomics Stock a Buy?

Even if you've never had to analyze a genome yourself, you'll probably agree that they're quite complicated. But what would you do if you did need to analyze a genome to diagnose a patient or solve

Is BP Stock a Buy?Photo, wide shot, wide-angle lens,  Coal company, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/0e838f13-fa33-4583-92e9-bf3375dacf70.png
Is BP Stock a Buy?

In the future, 2020 will likely be known as the year of the coronavirus pandemic. But there was another unsettling event that took place that only energy traders will likely remember: Oil prices

2 Top Dividend Stocks With Yields Over 5%
2 Top Dividend Stocks With Yields Over 5%

While high-flying growth stocks are exciting, it's hard to go wrong in the long run with quality dividend stocks. You're unlikely to snag the next 100-bagger if you're a dividend investor, but

Estate Planning: Supporting Your Loved Ones After You're Gone
Estate Planning: Supporting Your Loved Ones After You're Gone

As Valentine's Day approaches, it's time to think outside the box when it comes to gifts. After all, roses or candy are nice while they last, but the pleasure they provide is fleeting.

There is

3 High-Yield Dividend Investing Tips That Could Earn You Thousands
3 High-Yield Dividend Investing Tips That Could Earn You Thousands

Dividends are a nice way to earn a regular income, but if you're not careful, you might find that those payments are not as secure as you once thought.

Follow these easy steps to help ensure you

Here's Why the Novavax Vaccine May Have to Wait for FDA Authorization
Here's Why the Novavax Vaccine May Have to Wait for FDA Authorization

Novavax's (NASDAQ: NVAX) investigational coronavirus vaccine is on its way to the big finish line: regulatory authorization. The company recently reported positive phase 3 data. And now, regulatory

3 Top Dividend Stocks With Yields Over 4%
3 Top Dividend Stocks With Yields Over 4%

If you're going to invest in dividend stocks, you want to make it worth your while. The typical S&P 500 stock yields just 1.6%, but there are many other investments out there that yield a whole lot

1 Under-the-Radar SaaS IPO to Watch in 2021Photo, wide shot, wide-angle lens,  Semiconductor company, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/92ce44e9-64c7-4458-9a95-b706ed510490.png
1 Under-the-Radar SaaS IPO to Watch in 2021

Dozens of companies have chosen to go public through mergers with special purpose acquisition companies, or SPACs, already in 2021. And it doesn't look like the trend is slowing down. We recently

Here's Why You Can't Compare Vaccine Results Between Johnson & Johnson, Pfizer, and Moderna
Here's Why You Can't Compare Vaccine Results Between Johnson & Johnson, Pfizer, and Moderna

Johnson & Johnson (NYSE: JNJ) announced late-stage results for its COVID-19 vaccine in late January. The immediate focus was on the vaccine's efficacy, which was markedly lower than efficacy levels